Winters ME - Search Results

1

Protein microarrays: molecular profiling technologies for clinical specimens.

Espina V, Mehta AI, Winters ME, Calvert V, Wulfkuhle J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: winters me. Proteomics. 2003 Nov;3(11):2091-100. doi: 10.1002/pmic.200300592. Proteomics. 2003. PMID: 14595807 Review.

2

Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.

Charboneau L, Tory H, Chen T, Winters M, Petricoin EF 3rd, Liotta LA, Paweletz CP. Charboneau L, et al. Brief Funct Genomic Proteomic. 2002 Oct;1(3):305-15. doi: 10.1093/bfgp/1.3.305. Brief Funct Genomic Proteomic. 2002. PMID: 15239896 Review.

3

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

Petricoin EF 3rd, Bichsel VE, Calvert VS, Espina V, Winters M, Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, Sgroi DC, Munson PJ, Esserman LJ, Liotta LA. Petricoin EF 3rd, et al. J Clin Oncol. 2005 May 20;23(15):3614-21. doi: 10.1200/JCO.2005.02.509. J Clin Oncol. 2005. PMID: 15908672 Review.

4

Molecular diagnostics.

Braziel RM, Shipp MA, Feldman AL, Espina V, Winters M, Jaffe ES, Petricoin EF 3rd, Liotta LA. Braziel RM, et al. Hematology Am Soc Hematol Educ Program. 2003:279-93. doi: 10.1182/asheducation-2003.1.279. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633786 Review.

5

Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.

Winters ME, Mehta AI, Petricoin EF 3rd, Kohn EC, Liotta LA. Winters ME, et al. Cancer Res. 2005 May 1;65(9):3853-60. doi: 10.1158/0008-5472.CAN-04-1989. Cancer Res. 2005. PMID: 15867384

6

Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays.

Winters M, Dabir B, Yu M, Kohn EC. Winters M, et al. Proteomics. 2007 Nov;7(22):4066-8. doi: 10.1002/pmic.200700484. Proteomics. 2007. PMID: 17952872

7

Breast cancer growth prevention by statins.

Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Campbell MJ, et al. Cancer Res. 2006 Sep 1;66(17):8707-14. doi: 10.1158/0008-5472.CAN-05-4061. Cancer Res. 2006. PMID: 16951186

8

A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section.

Chu WS, Liang Q, Liu J, Wei MQ, Winters M, Liotta L, Sandberg G, Gong M. Chu WS, et al. Lab Invest. 2005 Nov;85(11):1416-28. doi: 10.1038/labinvest.3700337. Lab Invest. 2005. PMID: 16127423 Free article.

9

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z. Pernas FG, et al. Among authors: winters me. Clin Cancer Res. 2009 Apr 1;15(7):2361-72. doi: 10.1158/1078-0432.CCR-08-1011. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318490 Free PMC article.

10

The critical care literature 2022.

Winters ME, Hu K, Martinez JP, Mallemat H, Brady WJ. Winters ME, et al. Am J Emerg Med. 2024 Jun;80:123-131. doi: 10.1016/j.ajem.2024.03.028. Epub 2024 Apr 2. Am J Emerg Med. 2024. PMID: 38574434 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page